prognosis and treatment in high-risk mds
Published 4 years ago • 1.5K plays • Length 1:25Download video MP4
Download video MP3
Similar videos
-
1:34
perspectives on the management of low and high-risk mds
-
2:13
optimizing therapy for patients with high-risk mds
-
3:08
the treatment protocol for higher risk mds
-
2:02
unmet needs in high-risk mds and future therapeutic strategies
-
2:12
improving the treatment of low-risk mds: luspatercept, treatment sequencing & disease classification
-
7:11
treatment of older mds patients with bmt (bone marrow transplantation)
-
33:29
higher-risk mds and aml: how new guidelines are changing diagnosis, classification and management
-
4:48
managing and treating mds
-
1:55
mds genomics: diagnosis and prognosis
-
1:02
update on treatments for high- and low-risk mds
-
1:00
the role of non-covalent btk inhibitors in the treatment of non-hodgkin lymphoma
-
1:41
novel therapies for high-risk mds
-
1:41
using cytogenetics to improve the diagnosis and prognosis of mds & to predict response to treatment
-
10:18
classification of high-risk mutations in mds
-
3:15
mds: treating high and low-risk disease
-
4:16
pre-mds states: identifying patients at risk and using modern tools to improve prognosis
-
11:53
the optimal treatment of lower risk mds
-
3:38
a new set of treatment options for low-risk mds
-
0:59
the current challenges facing high-risk mds treatment
-
2:50
magrolimab azacitidine in untreated higher-risk mds
-
1:02
emerging treatment options for lower- and higher-risk mds and ongoing trials
-
1:26
current and emerging prognostic factors for mds/mpn